| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 3 821-834, Copyright © 1993 by American Association of Immunologists
ARTICLES |
R Thomas, LS Davis and PE Lipsky
Harold C. Simmons Arthritis Research Center, UT Southwestern Medical School, Dallas 75235.
Dendritic cells (DC) are potent APC that can be purified from cultured peripheral blood non-T cells. Because no specific cell surface marker has been found, the lineage of DC remains obscure. The purpose of these studies was to determine the circulating blood cells that could give rise to functional human DC. DC were enriched when purified by standard techniques from non-T cells that were treated with L-leucyl-L-leucine methyl ester, known to be toxic to monocytes and cytolytic cells. To determine whether monocytes or B cells could give rise to DC, fresh non- T cells were sorted into CD14+ monocytes, CD19+ B cells, and CD14- and CD19- cells. Although there was some enrichment for APC function by cultured nonadherent CD14- or CD19- cells, a marked enrichment for cells with dendritic morphology and potent APC function was found in the population that was sorted by the absence of expression of CD14, CD19, CD3, and CD16. More than 90% of the CD14-CD19-CD16-CD3- sorted cells, and of control DC, expressed the myeloid markers CD13 and CD33. Therefore, fresh non-T cells were sorted based on the expression of these myeloid markers. In comparison with CD33-CD14- B cells, some of the CD33+ cells expressed CD14 dimly. However, they were easily distinguished from monocytes, which intensely expressed CD14. CD33+CD14dim cells developed dendritic processes and were more potent APC than control DC, CD33+CD14+, or CD33-CD14- cells. Although freshly isolated CD33+CD14dim DC expressed a number of cell surface molecules also expressed by CD14+ monocytes, they demonstrated lower levels of lysosomal enzymes and a lack of FcR-mediated phagocytosis in comparison with monocytes. Differentiation of morphology and phenotype of CD33+CD14dim cells occurred within 6 to 36 h in culture. However, the CD33+CD14dim cells could effectively function as APC without prolonged preincubation to develop dendritic morphology. These data indicate that human blood DC arise from precursors that express the myeloid lineage markers CD13 and CD33, but are functionally distinct from classic CD14+ monocytes.
This article has been cited by other articles:
|
|
 |
|
  C.W. Cutler and R. Jotwani Dendritic Cells at the Oral Mucosal Interface Journal of Dental Research, August 1, 2006; 85(8): 678 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bayry, S. Lacroix-Desmazes, M. D. Kazatchkine, O. Hermine, D. F. Tough, and S. V. Kaveri Modulation of Dendritic Cell Maturation and Function by B Lymphocytes J. Immunol., July 1, 2005; 175(1): 15 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Cravens, M. W. Melkus, A. Padgett-Thomas, M. Islas-Ohlmayer, M. del P. Martin, and J. V. Garcia Development and Activation of Human Dendritic Cells In Vivo in a Xenograft Model of Human Hematopoiesis Stem Cells, February 1, 2005; 23(2): 264 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T R D J Radstake, A B Blom, A W Sloetjes, E O F van Gorselen, G J Pesman, L Engelen, R Torensma, W B van den Berg, C G Figdor, P L E M van Lent, et al. Increased Fc{gamma}RII expression and aberrant tumour necrosis factor {alpha} production by mature dendritic cells from patients with active rheumatoid arthritis Ann Rheum Dis, December 1, 2004; 63(12): 1556 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Teleshova, J. Kenney, J. Jones, J. Marshall, G. Van Nest, J. Dufour, R. Bohm, J. D. Lifson, A. Gettie, and M. Pope CpG-C Immunostimulatory Oligodeoxyribonucleotide Activation of Plasmacytoid Dendritic Cells in Rhesus Macaques to Augment the Activation of IFN-{gamma}-Secreting Simian Immunodeficiency Virus-Specific T Cells J. Immunol., August 1, 2004; 173(3): 1647 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pichyangkul, K. Yongvanitchit, U. Kum-arb, H. Hemmi, S. Akira, A. M. Krieg, D. G. Heppner, V. A. Stewart, H. Hasegawa, S. Looareesuwan, et al. Malaria Blood Stage Parasites Activate Human Plasmacytoid Dendritic Cells and Murine Dendritic Cells through a Toll-Like Receptor 9-Dependent Pathway J. Immunol., April 15, 2004; 172(8): 4926 - 4933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. de la Rosa, N. Longo, J. L. Rodriguez-Fernandez, A. Puig-Kroger, A. Pineda, A. L. Corbi, and P. Sanchez-Mateos Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration J. Leukoc. Biol., May 1, 2003; 73(5): 639 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Szabolcs, K.-D. Park, M. Reese, L. Marti, G. Broadwater, and J. Kurtzberg Absolute Values of Dendritic Cell Subsets in Bone Marrow, Cord Blood, and Peripheral Blood Enumerated by a Novel Method Stem Cells, May 1, 2003; 21(3): 296 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Banki, L. Kacani, B. Mullauer, D. Wilflingseder, G. Obermoser, H. Niederegger, H. Schennach, G. M. Sprinzl, N. Sepp, A. Erdei, et al. Cross-Linking of CD32 Induces Maturation of Human Monocyte-Derived Dendritic Cells Via NF-{kappa}B Signaling Pathway J. Immunol., April 15, 2003; 170(8): 3963 - 3970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D. Davis, M. Jefford, P. Parente, and J. Cebon Rational approaches to human cancer immunotherapy J. Leukoc. Biol., January 1, 2003; 73(1): 3 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Randolph, G. Sanchez-Schmitz, R. M. Liebman, and K. Schakel The CD16+ (Fc{gamma}RIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting J. Exp. Med., August 19, 2002; 196(4): 517 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Engering, S. J. van Vliet, T. B. H. Geijtenbeek, and Y. van Kooyk Subset of DC-SIGN+ dendritic cells in human blood transmits HIV-1 to T lymphocytes Blood, August 13, 2002; 100(5): 1780 - 1786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Hoffmann, J. Muller-Berghaus, R. L. Ferris, J. T. Johnson, W. J. Storkus, and T. L. Whiteside Alterations in the Frequency of Dendritic Cell Subsets in the Peripheral Circulation of Patients with Squamous Cell Carcinomas of the Head and Neck Clin. Cancer Res., June 1, 2002; 8(6): 1787 - 1793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Cutler, R. Jotwani, and B. Pulendran Dendritic Cells: Immune Saviors or Achilles' Heel? Infect. Immun., August 1, 2001; 69(8): 4703 - 4708. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yoshimura, J. Bondeson, B. M. J. Foxwell, F. M. Brennan, and M. Feldmann Effective antigen presentation by dendritic cells is NF-{{kappa}}B dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines Int. Immunol., May 1, 2001; 13(5): 675 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bauer, V. Redecke, J. W. Ellwart, B. Scherer, J.-P. Kremer, H. Wagner, and G. B. Lipford Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c-, CD123+ Dendritic Cells J. Immunol., April 15, 2001; 166(8): 5000 - 5007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dzionek, A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S. Miltenyi, D. W. Buck, and J. Schmitz BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood J. Immunol., December 1, 2000; 165(11): 6037 - 6046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fournier, L. Chalus, I. Durand, E. Garcia, J.-J. Pin, T. Churakova, S. Patel, C. Zlot, D. Gorman, S. Zurawski, et al. FDF03, a Novel Inhibitory Receptor of the Immunoglobulin Superfamily, Is Expressed by Human Dendritic and Myeloid Cells J. Immunol., August 1, 2000; 165(3): 1197 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tamada, K. Shimozaki, A. I. Chapoval, Y. Zhai, J. Su, S.-F. Chen, S.-L. Hsieh, S. Nagata, J. Ni, and L. Chen LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response J. Immunol., April 15, 2000; 164(8): 4105 - 4110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kohrgruber, N. Halanek, M. Groger, D. Winter, K. Rappersberger, M. Schmitt-Egenolf, G. Stingl, and D. Maurer Survival, Maturation, and Function of CD11c- and CD11c+ Peripheral Blood Dendritic Cells Are Differentially Regulated by Cytokines J. Immunol., September 15, 1999; 163(6): 3250 - 3259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ito, M. Inaba, K. Inaba, J. Toki, S. Sogo, T. Iguchi, Y. Adachi, K. Yamaguchi, R. Amakawa, J. Valladeau, et al. A CD1a+/CD11c+ Subset of Human Blood Dendritic Cells Is a Direct Precursor of Langerhans Cells J. Immunol., August 1, 1999; 163(3): 1409 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Sorg, G. Kogler, and P. Wernet Identification of Cord Blood Dendritic Cells as an Immature CD11c- Population Blood, April 1, 1999; 93(7): 2302 - 2307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Scheinecker, K. P. Machold, O. Majdic, P. Hocker, W. Knapp, and J. S. Smolen Initiation of the Autologous Mixed Lymphocyte Reaction Requires the Expression of Costimulatory Molecules B7-1 and B7-2 on Human Peripheral Blood Dendritic Cells J. Immunol., October 15, 1998; 161(8): 3966 - 3973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Strobl, C. Scheinecker, E. Riedl, B. Csmarits, C. Bello-Fernandez, W. F. Pickl, O. Majdic, and W. Knapp Identification of CD68+lin- Peripheral Blood Cells with Dendritic Precursor Characteristics J. Immunol., July 15, 1998; 161(2): 740 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Ahuja, S. Mummidi, H. L. Malech, and S. K. Ahuja Human Dendritic Cell (DC)-Based Anti-Infective Therapy: Engineering DCs to Secrete Functional IFN-{gamma} and IL-12 J. Immunol., July 15, 1998; 161(2): 868 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-g. Chen, Y. Shi, J. D. Smith, D. Choi, J. D. Geiger, and J. J. Mule The Role of Tumor Necrosis Factor alpha in Modulating the Quantity of Peripheral Blood-Derived, Cytokine-Driven Human Dendritic Cells and Its Role in Enhancing the Quality of Dendritic Cell Function in Presenting Soluble Antigens to CD4+ T Cells In Vitro Blood, June 15, 1998; 91(12): 4652 - 4661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Nepomuceno and A. J. Tenner C1qRP, the C1q Receptor That Enhances Phagocytosis, Is Detected Specifically in Human Cells of Myeloid Lineage, Endothelial Cells, and Platelets J. Immunol., February 15, 1998; 160(4): 1929 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jontell, T. Okiji, U. Dahlgren, and G. Bergenholtz Immune Defense Mechanisms of the Dental Pulp Critical Reviews in Oral Biology & Medicine, January 1, 1998; 9(2): 179 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shortman and C. Caux Dendritic Cell Development: Multiple Pathways to Nature's Adjuvants Stem Cells, November 1, 1997; 15(6): 409 - 419. [Abstract] [Full Text]
|
|
|
|
|
|
D. N.J. Hart Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response Blood, November 1, 1997; 90(9): 3245 - 3287. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Rothe, H. Gabriel, E. Kovacs, J. Klucken, J. Stohr, W. Kindermann, and G. Schmitz Peripheral Blood Mononuclear Phagocyte Subpopulations as Cellular Markers in Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1437 - 1447. [Abstract] [Full Text]
|
|
|
|
|
|
J. Young and R. Steinman The hematopoietic development of dendritic cells: a distinct pathway for myeloid differentiation Stem Cells, July 1, 1996; 14(4): 376 - 387. [Abstract]
|
|
|
|
|
|
R Thomas and P. Lipsky Dendritic cells: origin and differentiation Stem Cells, March 1, 1996; 14(2): 196 - 206. [Abstract]
|
|
|
|
 |
|
 G. Massard, M.-M. Tongio, J.-M. Wihlm, and G. Morand The Dendritic Cell Lineage: A Ubiquitous Antigen-Presenting Organization Ann. Thorac. Surg., January 1, 1996; 61(1): 252 - 258. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
